Argamate Articles
Japan launches for Lotriga and Argamate
11 January 2013
Astellas and Sanwa to co-promote kidney disease drugs in Japan
21 February 2012
Showing 1-2 of 2 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Italy's pharma market slump set to continue, warns GlobalData
- Pfizer to split-off remaining 80% interest in Zoetis
